Eli lilly tests how well new drug enters the body
NCT ID NCT06085482
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed Phase 1 study in 10 healthy adults measured how much of the drug LY3502970 enters the bloodstream after being taken by mouth compared to directly into a vein. The goal was to understand the drug's absorption and breakdown in the body. Results will guide dosing for future studies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
LY3502970 (oral and intravenous)
What this could lead to
If successful, this study helps determine the right dose for future trials of LY3502970.
What could go wrong
This is a very early, small study in healthy people, not patients. It only measures drug levels, not whether the drug works for any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Covance Clinical Research Inc
Madison, Wisconsin, 53704, United States